Zimmer Biomet has scored an FDA clearance for a new component of its total knee replacement offering, aimed at patients who ...

Zimmer Biomet (NYSE:ZBH) announced today that it received FDA 510(k) clearance for its Persona SoluTion porous plasma spray ...

Yesterday, the U.S. Supreme Court (SCOTUS) denied the petition for writ of certiorari filed in Zimmer Biomet Holdings, Inc. v ...

New Anatomically Shaped Asymmetric Stemless Design for Total Shoulder Replacement WARSAW, Ind., Dec. 13, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical ...

Zimmer Biomet had a strong 2024, bolstering its product lines and staying on top of orthopedic medtech trends.

Premarket Approval Application (“PMA”) Supplement approval for the Oxford Cementless Partial Knee. The approval is based on ...

For patients in the U.S., the Oxford Partial Knee is the only implant with a lifetime limited warranty that covers the cost of Zimmer Biomet replacement implants.* Important Safety Information ...

Key factors responsible for the potential market growth include the rising incidence of osteoarthritis and expanding demand ...

WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket ...

18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revision Knee System. This addition ...